| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877254 | The Annals of Thoracic Surgery | 2011 | 9 Pages |
Abstract
In this model, phosphodiesterase-5 inhibition using SDF prevented post-CPB acute kidney injury by the preservation of nitric oxide bioavailability, and warrants evaluation as a renoprotective agent in clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nishith N. MRCS, Hua MS, Tibor MD, MRCPath, Ceri BS, Paramita FRCA, Gavin I. PhD, Simon C. PhD, MRCP, Philippa BS, Gianni D. MD, FRCS, Gavin J. MD, FRCS,